BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 36906596)

  • 1. National, subnational and risk attributed burden of chronic respiratory diseases in Iran from 1990 to 2019.
    Heidari-Foroozan M; Aryan A; Esfahani Z; Shahrbaf MA; Moghaddam SS; Keykhaei M; Ghasemi E; Rashidi MM; Rezaei N; Ghamari SH; Abbasi-Kangevari M; Fateh SM; Farzi Y; Rezaei N; Larijani B
    Respir Res; 2023 Mar; 24(1):74. PubMed ID: 36906596
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The burden of chronic respiratory disease and attributable risk factors in North Africa and Middle East: findings from global burden of disease study (GBD) 2019.
    Fallahzadeh A; Sharifnejad Tehrani Y; Sheikhy A; Ghamari SH; Mohammadi E; Saeedi Moghaddam S; Esfahani Z; Nasserinejad M; Shobeiri P; Rashidi MM; Rezaei N; Heidari-Foroozan M; Rezaei N; Larijani B; Farzadfar F
    Respir Res; 2022 Sep; 23(1):268. PubMed ID: 36175873
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Global burden of chronic respiratory diseases and risk factors, 1990-2019: an update from the Global Burden of Disease Study 2019.
    GBD 2019 Chronic Respiratory Diseases Collaborators
    EClinicalMedicine; 2023 May; 59():101936. PubMed ID: 37229504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence and attributable health burden of chronic respiratory diseases, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.
    GBD Chronic Respiratory Disease Collaborators
    Lancet Respir Med; 2020 Jun; 8(6):585-596. PubMed ID: 32526187
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic risk factors attributed burden in Iran at national and subnational levels, 1990 to 2019.
    Moradi S; Parsaei A; Saeedi Moghaddam S; Aryannejad A; Azadnajafabad S; Rezaei N; Mashinchi B; Esfahani Z; Shobeiri P; Rezaei N; ; Naghavi M; Larijani B; Farzadfar F
    Front Public Health; 2023; 11():1149719. PubMed ID: 37325329
    [TBL] [Abstract][Full Text] [Related]  

  • 6. National and subnational burden of female and male breast cancer and risk factors in Iran from 1990 to 2019: results from the Global Burden of Disease study 2019.
    Aryannejad A; Saeedi Moghaddam S; Mashinchi B; Tabary M; Rezaei N; Shahin S; Rezaei N; ; Naghavi M; Larijani B; Farzadfar F
    Breast Cancer Res; 2023 Apr; 25(1):47. PubMed ID: 37101247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trends and risk factors of mortality and disability adjusted life years for chronic respiratory diseases from 1990 to 2017: systematic analysis for the Global Burden of Disease Study 2017.
    Li X; Cao X; Guo M; Xie M; Liu X
    BMJ; 2020 Feb; 368():m234. PubMed ID: 32075787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Global, regional and national burden of endocrine, metabolic, blood and immune disorders 1990-2019: a systematic analysis of the Global Burden of Disease study 2019.
    Wu J; Lin X; Huang X; Shen Y; Shan PF
    Front Endocrinol (Lausanne); 2023; 14():1101627. PubMed ID: 37223046
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trends in health burden of ambient particulate matter pollution in Iran, 1990-2010: findings from the Global Burden of Disease study 2010.
    Poursafa P; Kelishadi R; Ghasemian A; Sharifi F; Djalalinia S; Khajavi A; Nejatifar M; Asayesh H; Mansourian M; Qorbani M; Ansari H
    Environ Sci Pollut Res Int; 2015 Dec; 22(23):18645-53. PubMed ID: 26490896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. National and subnational burden of brain and central nervous system cancers in Iran, 1990-2019: Results from the global burden of disease study 2019.
    Mahdavi M; Moghaddam SS; Abbasi-Kangevari M; Mohammadi E; Shobeiri P; Sharifi G; Jafari A; Rezaei N; Ebrahimi N; Rezaei N; Ghamari SH; Malekpour MR; Khalili M; Larijani B; Kompani F
    Cancer Med; 2023 Apr; 12(7):8614-8628. PubMed ID: 36622061
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The burden of chronic respiratory diseases and their heterogeneity across the states of India: the Global Burden of Disease Study 1990-2016.
    India State-Level Disease Burden Initiative CRD Collaborators
    Lancet Glob Health; 2018 Dec; 6(12):e1363-e1374. PubMed ID: 30219316
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Burden of COPD in China and Its Provinces: Findings From the Global Burden of Disease Study 2019.
    Yin P; Wu J; Wang L; Luo C; Ouyang L; Tang X; Liu J; Liu Y; Qi J; Zhou M; Lai T
    Front Public Health; 2022; 10():859499. PubMed ID: 35757649
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Smoking: a leading factor for the death of chronic respiratory diseases derived from Global Burden of Disease Study 2019.
    Gan H; Hou X; Zhu Z; Xue M; Zhang T; Huang Z; Cheng ZJ; Sun B
    BMC Pulm Med; 2022 Apr; 22(1):149. PubMed ID: 35443660
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trends in prevalence and incidence of chronic respiratory diseases from 1990 to 2017.
    Xie M; Liu X; Cao X; Guo M; Li X
    Respir Res; 2020 Feb; 21(1):49. PubMed ID: 32046720
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distributions and trends of the global burden of COPD attributable to risk factors by SDI, age, and sex from 1990 to 2019: a systematic analysis of GBD 2019 data.
    Zou J; Sun T; Song X; Liu YM; Lei F; Chen MM; Chen Z; Zhang P; Ji YX; Zhang XJ; She ZG; Cai J; Luo Y; Wang P; Li H
    Respir Res; 2022 Apr; 23(1):90. PubMed ID: 35410227
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Global Burden of Chronic Respiratory Diseases.
    Viegi G; Maio S; Fasola S; Baldacci S
    J Aerosol Med Pulm Drug Deliv; 2020 Aug; 33(4):171-177. PubMed ID: 32423274
    [No Abstract]   [Full Text] [Related]  

  • 17. National and subnational burden of stroke in Iran from 1990 to 2019.
    Fallahzadeh A; Esfahani Z; Sheikhy A; Keykhaei M; Moghaddam SS; Tehrani YS; Rezaei N; Ghasemi E; Azadnajafabad S; Mohammadi E; Koolaji S; Shahin S; Rezaei N; Larijani B; Farzadfar F
    Ann Clin Transl Neurol; 2022 May; 9(5):669-683. PubMed ID: 35395141
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trends of national and sub-national burden attributed to kidney dysfunction risk factor in Iran: 1990-2019.
    Nejadghaderi SA; Saeedi Moghaddam S; Keykhaei M; Shobeiri P; Rezaei N; Rezaei N; Naghavi M; Larijani B; Farzadfar F
    Front Endocrinol (Lausanne); 2023; 14():1115833. PubMed ID: 36923218
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Burden of disease due to amphetamines, cannabis, cocaine, and opioid use disorders in South America, 1990-2019: a systematic analysis of the Global Burden of Disease Study 2019.
    Castaldelli-Maia JM; Wang YP; Brunoni AR; Faro A; Guimarães RA; Lucchetti G; Martorell M; Moreira RS; Pacheco-Barrios K; Rodriguez JAB; Roever L; Silva DAS; Tovani-Palone MR; Valdez PR; Zimmermann IR; Culbreth GT; Hay SI; Murray CJL; Bensenor IM
    Lancet Psychiatry; 2023 Feb; 10(2):85-97. PubMed ID: 36697127
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Burden of musculoskeletal disorders in Iran during 1990-2017: estimates from the Global Burden of Disease Study 2017.
    Shahrezaee M; Keshtkari S; Moradi-Lakeh M; Abbasifard M; Alipour V; Amini S; Arabloo J; Arzani A; Bakhshaei M; Barzegar A; Bijani A; Dianatinasab M; Eskandarieh S; Gheshlagh RG; Ghashghaee A; Heidari-Soureshjani R; Irvani SSN; Lahimchi A; Maleki S; Manafi N; Manafi A; Mansournia MA; Mohammadian-Hafshejani A; Bandpei MAM; Moradzadeh R; Naderi M; Pakshir K; Rafiei A; Rashedi V; Rezaei N; Rezapour A; Sahraian MA; Shahabi S; Shamsi M; Soheili A; Soroush A; Zamani M; Mohajer B; Farzadfar F
    Arch Osteoporos; 2020 Jul; 15(1):103. PubMed ID: 32651719
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.